Clinical Trial Update: Clinical Trial to Investigate Safety and Efficacy of Edoxaban in Patients With CTEPH (KABUKI) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of edoxaban in chronic thromboembolic pulmonary hypertension (CTEPH) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thromboembolic Pulmonary Hypertension

Drugs mentioned

• Edoxaban (edoxaban)

Snippet

Sponsor: Kyushu University | Conditions: CTEPH | Phase 3 | Status: COMPLETED